Abstract:The major targets of current drugs used in mental health, such as neurotransmitter receptors and transporters, are based on serendipitous findings from several decades ago, and there is currently a severe drought of new drug targets. There is a pressing need for novel drugs, and much hope has been placed on the use of molecular genetics to help define them. However, despite evidence for a genetic basis to schizophrenia stretching back for over a century, and a heritability of about 80%, the identification of susceptibility genes has been an uphill struggle. Candidate gene studies, which have generally focussed on obvious candidates from the dopamine and serotonin systems, as well as genes involved in brain development, have not generally been successful, although meta-analysis indicates that the dopamine D3 receptor gene (DRD3) and the serotonin receptor gene type 2A (HTR2A) may have a very small influence on risk. Linkage analysis has provided robust evidence of genetic loci, for example, on chromosomes 8p, 13q and 22q, and also implies shared genetic aetiology with bipolar disorder. The identification of these loci together with advances in genetic technology, especially the characterisation of polymorphisms, the understanding of haplotypes and the development of statistical methods, has lead to the identification of several plausible susceptibility genes, including neuregulin 1, proline dehydrogenase and dysbindin. Interestingly, these genes point more towards a role for the glutamate pathway rather than the dopamine pathway in schizophrenia. We have attempted to replicate some of these findings in schizophrenic patients from SW China, and we find significant association with a novel neuregulin 1 haplotype, with proline dehydrogenase polymorphisms, but not with catechol-O-methyltransferase (COMT). The replication of neuregulin 1 association on chromosome 8p by several investigators is the most convincing to date, and the presence of a syndrome similar to dementia praecox of 8p linked families, and the lack of linkage of bipolar disorder to this region is a testament to the ideas of Kraepelin more than 100 years ago.

No correlation between HLA-DQ 2.5, DQ 8.1 and DQ 6.2 and circulating levels of antibodies against gliadins in schizophrenia.

Differential Antibody Responses to Gliadin-Derived Indigestible Peptides in Patients with Schizophrenia

A Study of Circulating Gliadin Antibodies in Schizophrenia among a Chinese Population.

No Association Observed Between Schizophrenia and Non-Hla Coeliac Disease Genes: Integration with the Initial Myo9b Association with Coeliac Disease

Analysis on association between anti-gliadin IgA and anti-gliadin IgG antibodies and schizophrenia in Chinese Han population

The TGM2 Gene is Associated with Schizophrenia in a British Population.

A Study of Type-1 Diabetes Associated Autoantibodies in Schizophrenia

No association between schizophrenia and homozygosity at the D3 dopamine receptor gene.

Relationship Between HLA Class Ⅱ Gene Polymorphism and Schizophrenia

Antigliadin antibodies and the brain in people without celiac disease: a case-control study.

Potential Involvement of Human Leukocyte Antigen-DR/DQ Polymorphisms with Schizophrenia Among Patients with Schizophrenia in Yemen

Epitope Selection for HLA-DQ2 Presentation: Implications for Celiac Disease and Viral Defense

Study of Novel Autoantibodies in Schizophrenia.

P-1239 - Study of Association of the HLA-DRB1*13 Variants with Schizophrenia in a British Population

Autoantibodies Against Acetylcholine Receptors Are Increased in Archived Serum Samples from Patients with Schizophrenia

High frequency of low-risk human leukocyte antigen class II genotypes in latent celiac disease

Correlation of Functional GRIN2A Gene Promoter Polymorphisms with Schizophrenia and Serum D-serine Levels.

The genetics of schizophrenia: glutamate not dopamine?

The association of human leukocyte antigen class II (HLA II) haplotypes with the risk of Latent autoimmune diabetes of adults (LADA): Evidence based on available data

The functional significance of the TGM2 gene in schizophrenia: a correlation of SNPs and circulating IL-2 levels.

The Relationships Between HLA Class II Alleles and Antigens with Gestational Diabetes Mellitus: A Meta-Analysis